Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

85.86
Delayed Data
As of May 05
 +0.26 / +0.30%
Today’s Change
81.89
Today|||52-Week Range
123.37
-15.15%
Year-to-Date
7 Figures That Sum Up Merck & Co.'s First Quarter
May 05 / MotleyFool.com
Shire (SHPG) Tops Q1 Earnings, Baxalta Buyout Set for June
May 02 / Zacks.com
The Zacks Analyst Blog Highlights: Amgen, Gilead, Celgene, Medivation and Biogen
May 05 / Zacks.com
Good News: Gilead Sciences Discounted Its Drugs Again
May 02 / MotleyFool.com
Better Buy: Gilead Sciences vs. Biogen
May 04 / MotleyFool.com
Novo Nordisk (NVO) Beats on Q1 Earnings, Retains Outlook
May 02 / Zacks.com
Biotech Stock Roundup: Amgen Impresses, Gilead Disappoints in Q1, Biogen to Spin Off ...
May 04 / Zacks.com
Don't Give Up on Gilead Following a Weak Q1
May 02 / TheStreet.com
Drug Stocks Earnings Preview: GERN, RPRX, ICPT, AGIO & More
May 04 / Zacks.com
ImmunoGen (IMGN) Posts Wider-than-Expected Q3 Loss
May 02 / Zacks.com
Bank of America's 17 High-Quality Cash-Rich Stocks for Investors to Consider
May 04 / TheStreet.com
Stock Market News for May 02, 2016
May 02 / Zacks.com
3 Dirt-Cheap Biotech Stocks To Buy
May 04 / MotleyFool.com
Cramer: Get Ready for More Downgrades for Tech and Biotech
May 02 / TheStreet.com
What Sent Medivation, Inc.'s Shares Soaring 25.1% In April
May 03 / MotleyFool.com
U.S. Futures Start Week Strong as Asian Markets Falter
May 02 / TheStreet.com
5 Data Points Wall Street Is Anxiously Awaiting in Merck's Q1 Report
May 03 / MotleyFool.com
Reversal of Fortune: Energy Sector Fires Up as Tech and Health Fizzle
May 01 / TheStreet.com
SurModics (SRDX) Beats Q2 Earnings & Revenues Estimates
May 03 / Zacks.com
Does Healthcares Past Predict its Future?
May 01 / MotleyFool.com
Aduro (ADRO) Q1 Loss Wider than Expected, Revenues Fall
May 03 / Zacks.com
3 Key Pipeline Developments for Gilead Investors to Watch
Apr 30 / MotleyFool.com
There Are Many Reasons to be Optimistic About Gilead's Prospects
May 03 / GuruFocus News
Apple Drives Selloff on April's Last Trading Day
Apr 29 / TheStreet.com
3 Stocks Dragging In The Drugs Industry
May 03 / TheStreet.com
Market Lost in No-Man's Land -- Jim Cramer
Apr 29 / TheStreet.com
This New Stock Market Trend Is Catching Investors By Surprise (but It Shouldn't)
May 03 / MotleyFool.com
Cramer: The Market Needs New Leadership
Apr 29 / TheStreet.com
Mallinckrodt (MNK) Tops Q2 Earnings and Sales, Ups View
May 03 / Zacks.com
Stocks suffer worst week since February freakout
Apr 29 / CNNMoney.com
Alnylam (ALNY) Reports Wider-than-Expected Loss in Q1
May 03 / Zacks.com
Stocks Sell Off in Final Trading Day of April
Apr 29 / TheStreet.com
Merrimack (MACK) Posts Narrower-than-Expected Loss in Q1
May 03 / Zacks.com
Gilead (GILD) Stock Plunges as Maxim Downgrades on Weak Q1 Earnings
Apr 29 / TheStreet.com
2Q Is Going to Be Just as Dismal
May 03 / TheStreet.com
Gilead Sciences, Inc. Reports Disappointing Q1 Harvoni Sales
Apr 29 / MotleyFool.com
Mylan Beats on Q1 Earnings, Revenues Lag, 2016 View Intact
May 03 / Zacks.com
Trade-Ideas: Gilead (GILD) Is Today's "Water-Logged And Getting Wetter" Stock
Apr 29 / TheStreet.com
Aerie (AERI) Q1 Loss Wider than Expected, Pipeline in Focus
May 03 / Zacks.com
3 Drug Stocks Reporting Early Next Week: PFE, MYL, MNK
Apr 29 / Zacks.com
5 Strong Buy Dividend Stocks to Beat Sell-in-May Blues
May 03 / Zacks.com
Gilead Sciences (GILD) Earnings Report: Q1 2016 Conference Call Transcript
Apr 29 / TheStreet.com
How to Trade 5 Biotech Stocks After a Fall -- Plus Jim Cramer's Take
May 03 / TheStreet.com
The Motley Fools 10 Best Stock Calls of the Last 10 Years
Apr 29 / MotleyFool.com
Gilead Sciences Is Cannibalizing Its Own Sales, and Management Loves It
May 03 / MotleyFool.com
The Zacks Analyst Blog Highlights: Broadcom, Kellogg, Altria Group, Gilead Sciences a...
Apr 29 / Zacks.com
Cramer: Apple -- Stay or Go?
May 02 / TheStreet.com
Gilead (GILD) Lags Q1 Earnings & Revenues, '16 View Intact
Apr 29 / Zacks.com
Biotech ETFs Sink on Mixed Q1 Results
May 02 / Zacks.com
Stock Futures Slip as Consumers Save Instead of Spend
Apr 29 / TheStreet.com